9258 Wealth Management, LLC Neurocrine Biosciences Inc Transaction History

9258 Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$106.72 - $127.06 $179,289 - $213,460	1,680 New	1,680 $200,000
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $294,864 - $393,226	-3,702 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $1,699 - $1,943	19 Added 0.52%	3,702 $360,000
Q1 2021 May 11, 2021	SELL	$87.57 - $119.4 $6,217 - $8,477	-71 Reduced 1.89%	3,683 $358,000
Q4 2020 Feb 10, 2021	BUY	$86.91 - $108.33 $31,722 - $39,540	365 Added 10.77%	3,754 $360,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $8,750 - $12,298	91 Added 2.76%	3,389 $334,000
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $850 - $1,303	10 Added 0.3%	3,298 $402,000
Q1 2020 May 05, 2020	BUY	$75.11 - $113.76 $11,717 - $17,746	156 Added 4.98%	3,288 $334,000
Q4 2019 Feb 06, 2020	BUY	$86.8 - $118.57 $271,857 - $371,361	3,132 New	3,132 $337,000

626

94M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 9258 Wealth Management, LLC with notifications on news.